Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 2
1 (100.0%)Trial of Aganirsen in iCRVO Patients at Risk of Developing NVG
Phase 2
- Conditions
- Ischaemic Central Retinal Vein OcclusionNeovascular Glaucoma
- Interventions
- First Posted Date
- 2016-10-28
- Last Posted Date
- 2016-10-31
- Lead Sponsor
- Gene Signal SAS
- Target Recruit Count
- 333
- Registration Number
- NCT02947867
News
No news found